|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||1.69 / 14.81|
Stocks with insider trader activity include HEB, EPAY and STOR
National Institutes of Health Research Focus on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is Set to be a Game Changer for Patients
Both Viruses Transmitted by Identical Mosquito Family
Senior Management, Entire Board of Directors, and 100% of All Employees Participate
Long Term Exclusivity in Promising Novel Nucleic Acid Treatments Supported by Recent Issuance of a Broad Patent in European Union
Hemispherx' Next Step in the Fight to Treat Patients With MERS
Key May be Ampligen's Unique Immune Mechanism
...Quality of Life Improvements Were Related to Exercise Responses to Ampligen
Ampligen(R) Increases NK Activity More Than 100% in Vitro in a CFS Patient Population
Recent Manufacturing Open House Highlights Two Unique Products
Company to Update and Pursue Collection of at Least $770,852.76 in Attorney Fees and Costs Awarded to it in Delaware Contract Dispute
Important First Step to Resolve Raw Material Supply Delays Associated With BioLife Plasma Services' Breach of Long Term Supply Agreement With Hemispherx
Stocks with insider trader activity include SKT, HEB and NURO
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.